Evidence map›Paper›PMID 40943044›Full record

ArticleInternational journal of molecular sciences2025

Chemopreventive Potential of Artemisinin and

Maria Leticia de Almeida Lança, Nathan Steven Cezar da Conceição, Isabella Souza Malta, Daniela Oliveira Meneses, Luciana Yamamoto Almeida, Estela Kaminagakura

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Leticia de Almeida LançaDepartment of Bioscience and Oral Diagnosis, Institute of Science and Technology, University of São Paulo State, Avenue Engenheiro Francisco José Longo, 777, São José dos Campos, São Paulo 12245-000, Brazil.ORCID 0000-0001-5768-9281
Nathan Steven Cezar da ConceiçãoDepartment of Bioscience and Oral Diagnosis, Institute of Science and Technology, University of São Paulo State, Avenue Engenheiro Francisco José Longo, 777, São José dos Campos, São Paulo 12245-000, Brazil.
Isabella Souza MaltaDepartment of Bioscience and Oral Diagnosis, Institute of Science and Technology, University of São Paulo State, Avenue Engenheiro Francisco José Longo, 777, São José dos Campos, São Paulo 12245-000, Brazil.ORCID 0000-0002-3023-4620
Daniela Oliveira MenesesDepartment of Bioscience and Oral Diagnosis, Institute of Science and Technology, University of São Paulo State, Avenue Engenheiro Francisco José Longo, 777, São José dos Campos, São Paulo 12245-000, Brazil.ORCID 0009-0001-7136-2370
Luciana Yamamoto AlmeidaDepartment of Bioscience and Oral Diagnosis, Institute of Science and Technology, University of São Paulo State, Avenue Engenheiro Francisco José Longo, 777, São José dos Campos, São Paulo 12245-000, Brazil.ORCID 0000-0001-5403-4052
Estela KaminagakuraDepartment of Bioscience and Oral Diagnosis, Institute of Science and Technology, University of São Paulo State, Avenue Engenheiro Francisco José Longo, 777, São José dos Campos, São Paulo 12245-000, Brazil.ORCID 0000-0003-2456-4516

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 20/07375-3
6 · The paper itself

Abstract

Oral leukoplakia (OL) is the most common potentially malignant oral disorder, with variable risk of progression to oral squamous cell carcinoma (OSCC). This study evaluated the chemopreventive and immunomodulatory potential of Artemisinin (ART) and

Indexed as

ArtemisininsLeukoplakia, OralMouth Neoplasms4-Nitroquinoline-1-oxideAnimalsApoptosisDisease Models, AnimalDisease ProgressionFemaleMaleMiceQuinolones4-Nitroquinoline-1-oxide4-nitroquinolone-1-oxideartemisininArtemisininsQuinolones4-Nitroquinoline-1-oxideArtemisininsBlack Raspberrychemopreventionoral leukoplakiasquamous cell carcinoma of the head and neck

Identifiers

PMID40943044
PMCPMC12428017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.